June 8, 2005 — The U.S. Food and Drug Administration (FDA) approved in March revisions to safety labeling to advise that use of rosuvastatin calcium tablets is associated with an increased risk of ...
Short-term use of acetazolamide was shown to improve both obstructive sleep apnea (OSA) and central sleep apnea (CSA), with significantly greater reductions in the apnea-hypopnea index observed with ...
The Department of Pharmaceuticals (DoP) has rejected the review application of Sun Pharma Laboratories filed against the retail price fixed by the National Pharmaceutical Pricing Authority’s (NPPA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback